MSAM
PAVM icon

Moloney Securities Asset Management’s PAVmed PAVM Stock Holding History

Moloney Securities Asset Management’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-25
Closed -$11K – 368
2019
Q3 		$11K Hold
25
– – ﹤0.01% 327
2019
Q2 		$13K Hold
25
– – ﹤0.01% 319
2019
Q1 		$13K Sell
25
-2
-7% -$916 ﹤0.01% 301
2018
Q4 		$11K Sell
27
-43
-61% -$21.1K ﹤0.01% 281
2018
Q3 		$41K Sell
70
-1
-1% -$610 0.01% 295
2018
Q2 		$30K Sell
71
-2
-3% -$1.22K 0.01% 292
2018
Q1 		$54K Buy
73
+41
+128% +$35.1K 0.02% 284
2017
Q4 		$33K Sell
32
-1
-3% -$1.76K 0.01% 265
2017
Q3 		$80K Buy
33
+1
+3% +$2.07K 0.04% 264
2017
Q2 		$66K Hold
32
– – 0.03% 246
2017
Q1 		$73K Sell
32
-17
-35% -$45.8K 0.04% 234
2016
Q4 		$152K Buy
+49
New +$205K 0.09% 203

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

Moloney Securities Asset Management's PAVM Position: Q4 2019 in Review

Moloney Securities Asset Management sold out of PAVmed (PAVM) in Q4 2019, closing a stake of 25 shares — an estimated $11K sold.

Moloney Securities Asset Management first reported a position in PAVM in Q4 2016 and held it in 12 quarters. The position peaked at $152K in Q4 2016. 15 funds tracked by Wall St. Rank hold PAVM as of Q4 2019.

  • Moloney Securities Asset Management reported no remaining PAVmed position as of Q4 2019 after selling out during the quarter.
  • Moloney Securities Asset Management sold 25 PAVmed shares in Q4 2019, an estimated $11K.
  • Moloney Securities Asset Management first reported a position in PAVmed in Q4 2016 and held it in 12 quarters.
  • Moloney Securities Asset Management's PAVmed position peaked at $152K in Q4 2016.
  • 15 funds tracked by Wall St. Rank held PAVmed as of Q4 2019.

Based on Moloney Securities Asset Management's 13F filing for Q4 2019, filed 6 Feb 2020.